• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Aspen API. More than just an API™

    Breye Therapeutics completes Phase 1b trial with danegaptide

    PR NEWSWIRE

    Breye Commences Oral Dosing of Danegaptide in Patients with Diabetic Retinopathy

    PR NEWSWIRE

    Golgi & Breye announce closing of P2X7 receptor Program

    PR NEWSWIRE

    Breye Therapeutics Strengthens Management Team and Board

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.